Neurodevelopmental outcomes of infants secondary to in utero exposure to maternal SARS-CoV-2 infection: A national prospective study in Kuwait

Background

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease-19 (COVID-19), has been spreading rapidly worldwide, increasingly affecting even pregnant females. Pregnancy-associated physiological changes, as well as altered cell-mediated immunity, enhance the susceptibility of pregnant women to infections by intracellular organisms such as viruses. Based on a living systematic review and meta-analysis, overall, 10% (95% confidence interval (CI): 7-12%; 73 studies involving 67271 women) of pregnant and recently pregnant women attending or admitted to the hospital for any reason were diagnosed as having suspected or confirmed SARS-CoV-2 infection [1]. Hence, a growing proportion of pregnant women become infected with SARS-CoV-2 during various trimesters of pregnancy, with variable effects on the fetus [1,2].

Furthermore, the underdeveloped innate and adaptive immune systems of fetuses and neonates also make them more susceptible to infections [3, 4]. Maternal-fetal transmission of SARS-CoV-2 has not been widely established to date, and findings vary. A meta-analysis revealed that vertical transmission of SARS-CoV-2 is possible and showed that only 3.2% (27 of 936; 95% CI: 2.2-4.3) of neonates from mothers infected with SARS-CoV-2 had a positive result based on viral RNA testing of nasopharyngeal swabs [5]. SARS-CoV-2 viral RNA testing was positive in neonatal cord blood (2.9% samples), placental swabs (7.7%), and fecal or rectal swabs, whereas it was negative in urine and amniotic fluid samples. In contrast, a more recent systematic review article (2021), which covered the database up to September 2020, reported that newborn rates of the infection vary between 0% and 11.5% [6]. Nevertheless, due to the availability of only a few patients and studies, the exact rates of vertical transmission and fetal or neonatal morbidity and mortality cannot be ascertained.

Although SARS-CoV-2 primarily causes respiratory distress, it is also known to have extrapulmonary manifestations, including hematological, cardiovascular, endocrinological, and neurological complications, in the adult population [7-9]. Of these, neurological manifestations in pregnant women and their probable effect on fetuses and neonates are of primary concern. SARS-CoV-2 may gain entry into the central nervous system through the nasal mucosa, lamina cribrosa, and olfactory bulb or through retrograde axonal transport. SARS-CoV-2 also exhibits neurovirulence, triggering proinflammatory and prothrombotic cascades in the wake of cytokine storms, affecting brain vasculature, as well as the blood-brain barrier, mainly in the setting of the toxic-metabolic sequelae of multiorgan dysfunction frequently observed in SARS-CoV-2-positive patients [10,11]. Proinflammatory cytokines inhibit the proliferation of neuronal precursor cells, activate astrogliosis, and stimulate oligodendrocyte cell death, leading to abnormal neurodevelopment [3, 4]. Moreover, the elevated levels of maternal inflammatory cytokines (IL-1, IL-6, IL-8, and TNF-α) as a consequence of infection during pregnancy can disturb several characteristics of fetal brain development [12]. Notably, these pathological changes, which include deteriorated neuronal functions and atypical behavioral changes, can subsequently be seen in postnatal life and may increase the risk of schizophrenia, autism, and mental disorders [12, 13].

Additionally, animal studies have shown that offspring from maternal immune activation animal models have schizophrenia and autism-related behaviors, including decreased sensorimotor gating, deficits in working memory and cognitive flexibility, increased anxiety, and enhanced sensitivity to amphetamines [14-16].

Because of the plausible effects on neonates born to mothers with SARS-CoV-2 infections during pregnancy, this study assessed the developmental attainment at 10-12 months of neonates born to a cohort of mothers with SARS-CoV-2 infections during pregnancy in Kuwait using the Ages and Stages Questionnaire, 3rd edition (ASQ-3).

2 Methods

3 Results

Eight hundred forty pregnant women were identified from the national COVID-19 registry between April 1 and August 30, 2020. Four hundred forty-five women gave birth during the study period (Figure 1). One infant died on the first day of life due to severe birth asphyxia; 298 (67%) had complete follow-up at 10-12 months corrected age, and 146 (32.8%) infants were lost to follow-up. The main reason for the loss to follow-up was the inability to contact the parents due to either invalid contact information or parents having left the country. To determine whether the infants we lost to follow-up were representative of the complete study and to avoid attrition bias, we compared the baseline features of those infants with follow-up data with the baseline features of infants who were lost to follow-up. We did not find any statistically significant differences between these two groups.

• Download figure
• Open in new tab

Figure 1: Flowchart of the study recruitment and follow-up. ASQ-3: Ages and Stages Questionnaire, 3rd edition

The maternal and neonatal characteristics of the cohort are shown in Table 1.

Among the infants with completed ASQ-3, 5 (1.7%) were born to mothers diagnosed with SARS-CoV-2 during the first trimester, 20 (6.7%) during the second trimester, and 273 (91.6%) during the third trimester. Only 2 (0.7%) neonates tested positive for SARS-CoV-2 infection. Twenty-eight infants needed hospitalization beyond the first 8-10 months of age.

Parental questionnaires were collected at a median of 10.3 months corrected age (IQR 10 to 12.7). Developmental delays were identified in 30 (10.1%) of the infants. Of those with developmental delays, 3.3% (1/30) had delays in the communication domains, 27% (8/30) in the gross motor domain, 40% (12/30) in the fine motor domain, 10% (3/30) in the problem-solving domain, and 30% (9/30) in the personal-social domain (Figure 2).

• Download figure
• Open in new tab

Figure 2: Developmental outcome using the Ages and Stages Questionnaire, 3rd edition, at 10-12 months of age

A bar graph presenting the total score and subscale scores of ASQ-3 domains.

A score with a standard deviation (SD) ≤ 2 below the population mean implies developmental delays, and a score with an SD >2 above the population mean is considered no delay.

In the infants with developmental delays, 4 had concerns in two or more domains, and none had concerns in all domains.

Infants with developmental delays did not differ in terms of maternal age, maternal comorbidities, parental education level, severe maternal COVID-19, or the mode of delivery compared to those with no delay (Table 2). However, the occurrence of developmental delays differed significantly on the basis of the trimester at SARS-CoV-2 infection. Developmental delays were more common in infants born to mothers with COVID-19 during the first and second trimesters than in infants born to mothers with COVID-19 during the third trimester (P<0.001). Among infants with developmental delays, 4 (13.3%) were born to mothers with SARS-CoV-2 infection during the first trimester, 6 (20%) were born to mothers with SARS-CoV-2 infection during the second trimester, and 20 (66.7%) were born to mothers with SARS-CoV-2 infection in the third trimester. One (0.4%) of the infants without delay was born to a mother with SARS-CoV-2 infection in the first trimester, 14 (5.2%) were born to mothers with SARS-CoV-2 infections in the second trimester, and 253 (94.4%) were born to mothers with SARS-CoV-2 infections in the third trimester. Moreover, infants born at less than 31 weeks gestation were more likely to have developmental delays than infants born at more than 31 weeks gestation (10% versus 0.8%; P=0.002). Neonatal characteristics were similar between the groups.

In multivariate logistic regression analysis, adjusting for maternal age, parental educational level, gestational age, birth weight, and the type of feeding in the first six months of age, the risk of developmental delays was higher with first-trimester maternal SARS-CoV-2 infection (aOR: 8.2, 95% CI: 1.1-55.9; P=0.039) and second-trimester maternal SARS-CoV-2 infection (aOR: 8.1, 95% CI: 2.4-27.7; P=0.001) than with third-trimester maternal SARS-CoV-2 infection (Table 3).

4 Discussions

The fetal inflammatory response (FIRS) due to maternal SARS-CoV-2 infection can contribute to severe neonatal morbidity, which includes stillbirth, neonatal death, preterm birth, low birth weight, fetal distress, and neonatal asphyxia [19-21]. This is perhaps the first study reporting neurological assessments of neonates born to mothers from West Asia with SARS-CoV-2-positive RT-PCR test results during pregnancy using the ASQ-3. The findings of this study indicate that infants born to mothers who test positive for SARS-CoV-2 infection during pregnancy need to be assessed for neurodevelopmental delays.

To assess the developmental attainment of infants born to mothers with SARS-CoV-2-positive test results during pregnancy, this study employed the ASQ-3, a screening tool used for assessing the developmental attainment of infants and young children [18]. This screening tool is used widely in assessing development in children aged 1–66 months at a low cost, with cutoff scores identifying developmental delays. In the current study, an Arabic version of the ASQ-3 was used for mothers who were well versed in Arabic. Since the study cohort included diverse as well as immigrant mothers, questionnaires were sent to mothers, and fortunately, the majority of them consented to respond.

The study data revealed that the majority (91.6%) of the pregnant women had SARS-CoV-2 infection during their third trimester, whereas 6.7% had SARS-CoV-2 infection in their second trimester. This finding is in agreement with those of other studies that have also reported that most SARS-CoV-2 infections in pregnant women occur in their third trimester [22, 23]. In the current study, only a relatively small number of women were infected during the first trimester. However, first-trimester infections are important as the principal stages of brain development, such as primary neurulation (weeks 3–4), prosencephalic development (months 2–3), and neuronal proliferation (months 3–4), occur during the early stages of pregnancy [24]. In fact, infections with some common pathogens, such as cytomegalovirus (CMV), Zika virus, Rubella virus, Mycobacterium tuberculosis (TB), and Toxoplasma gondii, during the first and early second trimesters increase the risk of symptomatic infants, with up to 32% being associated with neurological manifestations [25]. Owing to the relatively recent emergence of COVID-19, information related to pregnancy outcomes among women with SARS-CoV-2 infection and the consequences of infant exposure to the virus is very scarce. As more women become infected during their first and second trimesters progress in their pregnancy and as newborns with SARS-CoV-2 infection develop, a better understanding of the neurological effects of this novel virus will emerge. In brief, various types of evidence support the theory that maternal infection and/or inflammation occurring during critical periods of fetal development could alter brain structure and function in a time-sensitive manner.

Nevertheless, SARS-CoV-2 infection increases the chances of fetal distress, leading to high incidences of admission to the neonatal intensive care unit (NICU) [23]. Similar to other reported studies, in the current study, 76 out of 298 (25.5%) neonates born to mothers with SARS-CoV-2-infection during pregnancy required NICU admission [26-29]. On the other hand, a systematic review reported that approximately 95% of neonates born to mothers with SARS-CoV-2 infection during pregnancy were born in good condition [1].

Recent evidence suggests that vertical transmission of SARS-CoV-2 either antenatally or intrapartum can occur, but it is uncommon. In this study, only 2 (0.7%) neonates tested positive for SARS-CoV-2 infection, and notwithstanding some seemingly perinatal complications, the majority of neonates (296 out 298) born were negative for SARS-CoV-2 infection. Our observation is in agreement with those of other studies [30-32], which implies that the consequences of SARS-CoV-2 infection on neurodevelopment were largely due to in utero effects rather than direct effects on the fetus. The reason for the low vertical transmission rate is that the placenta has low expression of the canonical receptors necessary for viral entry, which may explain the rarity of vertical transmission of SARS-CoV-2 [32]. Importantly, teratogenic effects of SARS-CoV-2 on the fetus were not observed, which is in contrast to other viral infections, such as Middle East respiratory syndrome coronavirus, CMV, herpes virus, Zika virus, and Rubella virus infections [33-37].

In this study, we evaluated the infant’s neurobehavioral development 10-12 months post discharge, perhaps the adequate duration for effects to appear. In this study, overall, 69.1% of neonates at the end of 10-12 months showed normal developmental attainment, and only 10.1% (n=30) showed developmental delays. The PregCOV-19 living systematic review [1] found that approximately 95% of neonates born to SARS-CoV-2-positive mothers were reported to be born in good condition. However, it is not clear whether this systematic review included evaluations of neurodevelopmental delays in neonates. A study from the UK, in which information about educational and behavioral problems was collected from 177 children, found that 25% required support from a nonteaching assistant, 4% required a statement of special educational needs, and 3% were in a special school [38]. Many investigators have studied the effects of various viral infections, albeit not SARS-CoV-2, on pregnancy and fetal/neonatal outcomes and have reported that maternal influenza, hepatitis C, varicella-zoster, and other viruses produce distinct fetal brain structure and anatomy clinical pathology of varying severity [39-42].

Of note, the role of cytokine storms, particularly the role of IL-6 in the pathogenesis of neurodevelopmental disorders, is not fully elucidated; however, in a longitudinal study, alterations in brain architecture, executive function, and working memory abilities were reported in 2-year-old neonates exposed to increased IL-6 levels during pregnancy [43]. An analysis of 214 patients with SARS-CoV-2 infection revealed that 36% had neurological symptoms [44]. Many case-control studies have demonstrated that elevated maternal cytokine levels affect the fetal brain, causing neurological disease [45-47]. The FIRS, due to increased IL-6 following maternal SARS-CoV-2 infection [13], may induce a wide range of adverse neurodevelopmental sequelae, such as autism, psychosis, and neurosensory deficits, later in life [48], similar to certain bacterial infections [49]. However, long-term longitudinal studies are required to validate these associations.

Moreover, the risk of neurological effects on neonates differs by the trimester when SARS-CoV-2 infection occurred [50]. In this study, developmental delays were relatively more prevalent when infection occurred in the first and second trimesters than when infection occurred in the third trimester (P<0.001). Neonatal characteristics were similar between the groups. Moreover, infants born at less than 31 weeks gestation were more likely to have developmental delays than those born at more than 31 weeks gestation (10% versus 0.8%; P=0.002).

The findings of the study may be considered reliable, as the cohort of parents who participated in the study was well educated, and women were young (median age: 31 years). Three-fourths of women were devoid of pregnancy-induced hypertension or gestational diabetes.

5 Strength and Limitations

This is perhaps the first study reporting neurological assessments of neonates born to mothers with SARS-CoV-2-positive RT-PCR test results during pregnancy using the ASQ-3. The participating mothers were from the local area, which enabled good tracking for follow-ups. Participants were educated and responded to ASQ-3 questions appropriately. Thus, these points may be regarded as strength of the study.

This study also has a few limitations, the most important aspects of which are related to the sample size and methodology. For stronger conclusions, a larger and statistically valid sample size is required. Furthermore, the ASQ-3 were completed by the parents of the neonates; hence, biases in reporting cannot be ruled out. Nevertheless, this initial study may help healthcare authorities understand the need to assess the developmental attainment of infants born to mothers with SARS-CoV-2-positive test results during pregnancy. The ASQ-3, although a good screening tool, has limitations, and its results may not be strongly comparable to those of other tools, such as the Bayley III test; therefore, further larger studies with formal assessments of neurodevelopment are warranted.

6 Conclusions

This study was a hypothesis-generating study, and the findings based on a screening tool raise some concerns regarding neurodevelopmental effects on fetuses born to mothers with SARS-CoV-2-positive test results during pregnancy. A majority of the pregnant women had SARS-CoV-2 infections during their third trimester. Developmental delays were more prevalent when SARS-CoV-2 infection occurred in the first and second trimesters than when it occurred in the third trimester. Infants born at less than 31 weeks gestation were more likely to have developmental delays than those born at more than 31 weeks gestation. Further larger studies with formal developmental assessments are warranted to study the effect of SARS-CoV-2 on the developing brain.

Declarations